Bruker acquires Scientific Software Provider Arxspan
Enhanced Focus on Pharma and Biopharma Software and Workflow Solutions
Bruker can now provide a range of software tools for customers in the chemistry, pharmaceutical, biopharma and analytical laboratory markets. Together with the Mestrelab strategic partnership and majority investment, the acquisition of Arxspan will allow Bruker to offer state-of-the-art chemistry and biopharma software tools, supporting discovery and development.
Commenting on the acquisition, Dr. Falko Busse, Group President for Bruker Biospin, stated: "The Arxspan acquisition, coupled with our strategic partnership with Mestrelab, positions Bruker firmly in the field of cloud-based, scientific software for our chemistry and pharma customers. Bruker is committed to providing intuitive end-to-end solutions that make analysis and knowledge extraction in scientific research faster and easier. Our new software solutions enable our biopharma customers to increase their productivity in drug discovery and development."
Peter Rosati, the CEO and a co-founder of Arxspan, commented: "We are excited that Arxspan is now part of a leading global life science tools company. The merger with Bruker will increase our footprint and help us support and grow our increasingly global customer base. We are focused on showing immediate benefits of the merger to our pharma and biopharma customers. Arxspan's proven enterprise SaaS platform will be a solid foundation for Bruker's chemistry and biology informatics offerings."
Most read news
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.